NCT01727414 - Attention Deficit Disorder Medication Response Study | Biotech Hunter

Enrollment

171

Participants

Timeline

Start Date

June 30, 2006

Primary Completion Date

July 31, 2013

Study Completion Date

July 31, 2014

Conditions

ADHD - Inattentive TypeADHD - Combined Type

Interventions

DRUG

OROS-Methylphenidate and placebo for inattentive type pts

Every participant receives low dose MPH, medium dose MPH, high dose MPH, and placebo for one week each in a triple-blinded fashion.

DRUG

OROS-Methylphenidate and placebo for combined type pts

Every participant receives low dose MPH, medium dose MPH, high dose MPH, and placebo for one week each in a triple-blinded fashion.

Trial Locations (1)

Children's Hospital Medical Center, Cincinnati

All Listed Sponsors

collaborator

National Institute of Mental Health (NIMH)

NIH

lead

Children's Hospital Medical Center, Cincinnati

OTHER